When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DNLI - Denali pivots on neuro candidate on safety signals
Denali Therapeutics Inc.
Citing adverse findings from primate toxicity studies, Denali Therapeutics (NASDAQ:DNLI), together with collaboration partner Sanofi (NASDAQ:SNY), has decided to halt Phase 1b clinical trials evaluating RIPK1 inhibitor DNL747 in Alzheimer's disease and ALS and focus its resources on accelerating development of DNL788 which, it says, has superior drug properties.
More news on: Denali Therapeutics Inc., Sanofi, Healthcare stocks news, Stocks on the move,